Fusion Pharmaceuticals Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the first quarter 2024 to a ratio of 74.18, above the company average. This is a clear sign of healthy business climate in the Biotechnology & Pharmaceuticals industry and improving liquidity at their respective customers, during the first quarter 2024. Average receivable collection period, for the Fusion Pharmaceuticals Inc in Mar 31 2024 quarter, has decreased to 5 days, compared to 9 days, in the Dec 31 2023 quarter.

If we take a look into Healthcare sector Fusion Pharmaceuticals Inc achieved the highest receivable turnover ratio. While receivables turnover ratio remained unchanged relative to the previous period at no. .

What is Receivable Turnover Ratio?
What is Fusion Pharmaceuticals Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

FUSN Receivables Turnover Ratio	(Mar 31 2024) I. Quarter	(Dec 31 2023) IV. Quarter	(Sep 30 2023) III. Quarter	(Jun 30 2023) II. Quarter	(Mar 31 2023) I. Quarter
Y / Y Receivable Change	-	-88.52 %	-80.93 %	-64.97 %	-72.62 %
Y / Y Revenue Change	-	-100 %	1108.43 %	-94.04 %	-95.21 %
Receivable Turnover Ratio (TTM)	74.18	41.57	34.91	3.45	6.67
FUSN's Total Ranking	#	#	#	#	#
Accounts Receivable average collection period days	5	9	10	106	55
Seq. Receivable Change	-	-82.93 %	-33.87 %	-30.34 %	45.9 %
Seq. Revenue Change	-	-100 %	5800 %	21.43 %	-80 %

Receivable Turnover Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	#
Healthcare Sector	#
Overall Market	#

Receivable Turnover Ratio Statistics
High	Average	Low
0	0	0

FUSN Company Profile • Back to FUSN Efficiency Comparisons • Compare FUSN Receivables Turnover Ratio to its Competitors

Financial Statements
Fusion Pharmaceuticals Inc 's Accounts Receivable	$ 0 Millions	Visit FUSN's Balance sheet
Fusion Pharmaceuticals Inc 's Sales TTM	$ 2 Millions	Visit FUSN's Income Statement
Sources of FUSN's Revenues		Visit FUSN's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
FUSN's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
FUSN's Growth Rates	FUSN's Roa	FUSN's Inventory Turnover Ratio	FUSN's Dividend Comparisons
FUSN's Profitability Ratios	FUSN's Roi	FUSN's Asset Turnover Ratio	FUSN's Dividend Growth
FUSN's Valuation Ratios	FUSN's Roe	FUSN's Financial Strength Ratios	FUSN's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2024, within Healthcare Sector

Receivable Turnover Ratio

Revenues for 12 Months ending Mar 31 2024

Receivable at quarter ending Mar 31 2024

Date modified: 2026-09-08T15:22:13+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.